ZLAB Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $24.33

Capitalizzazione di Mercato (MRQ) $27.31B

P/E (TTM) -135.2

EPS (TTM) $-0.18

Ricavi (TTM) $450M

ROE (TTM) -26.9%

D/E Debito/Patrimonio (MRQ) 0.4

Intervallo 52 sett. $16–$34

ZLAB Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Zai Lab Limited - American Depositary Shares Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti1.784 paeseCN

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$460M

2018-12-31 → 2025-12-31

EPS$-0.16

2020-12-31 → 2025-12-31

Flusso di cassa libero$-159M

2020-12-31 → 2025-12-31

Margine netto-41.9%

2020-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	ZLAB	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-135.2media 5 anni ≈-87.7	≈-87.7	·	·
P/S (TTM)	60.7media 5 anni ≈63.6	≈63.6	·	·
P/B (MRQ)	45.0media 5 anni ≈24.6	≈24.6	·	·
EV / EBITDA (TTM)	-108.5	·	·	·
Prezzo / FCF (TTM)	-195.7media 5 anni ≈-97.7	≈-97.7	·	·
Prezzo / Flusso di cassa (TTM)	-204.7media 5 anni ≈-101.5	≈-101.5	·	·
EV / Ricavi (TTM)	59.9	·	·	·
EV / FCF (TTM)	-192.9	·	·	·
Prezzo / Valore contabile tangibile (MRQ)	52.4media 5 anni ≈26.6	≈26.6	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	ZLAB	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-58.7%media 5 anni ≈-185.8%	≈-185.8%	·	·
Margine EBITDA (TTM)	-55.2%media 5 anni ≈-182.2%	≈-182.2%	·	·
Margine ante imposte (TTM)	-42.4%media 5 anni ≈-179.0%	≈-179.0%	·	·
Margine di Profitto Netto (TTM)	-41.9%media 5 anni ≈-179.1%	≈-179.1%	·	·
ROA (TTM)	-16.8%media 5 anni ≈-29.0%	≈-29.0%	·	·
ROE (TTM)	-26.9%media 5 anni ≈-36.2%	≈-36.2%	·	·
ROIC	-24.5%media 5 anni ≈-33.2%	≈-33.2%	·	·

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	ZLAB	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	0.4	·	·	·
Rapporto corrente (MRQ)	2.1media 5 anni ≈4.6	≈4.6	·	·
Quick Ratio (MRQ)	1.6media 5 anni ≈4.2	≈4.2	·	·

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	ZLAB	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	15.3%media 5 anni ≈66.5%	≈66.5%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	28.9%media 5 anni ≈48.4%	≈48.4%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	56.5%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	ZLAB	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.16media 5 anni ≈$-0.40	≈$-0.40	·	·
Revenue / Share (Ricavi / Azione)	$0.42media 5 anni ≈$0.37	≈$0.37	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-0.14media 5 anni ≈$-0.19	≈$-0.19	·	·
Cash / Share (Liquidità / Azione)	$0.61media 5 anni ≈$2.98	≈$2.98	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	ZLAB	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.4media 5 anni ≈0.3	≈0.3	·	·
Inventory Turnover (Rotazione delle scorte)	3.3media 5 anni ≈3.1	≈3.1	·	·
Receivables Turnover (Rotazione dei crediti)	4.8media 5 anni ≈5.3	≈5.3	·	·
Revenue / Employee (Ricavi / Dipendente)	≈$257.9K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 17.0%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$-0.05	$-0.07	24.0%
31 Marzo 2026	$-0.05	$-0.05	-4.4%
31 Dicembre 2025	$-0.05	$-0.07	24.0%
30 Settembre 2025	$-0.03	$-0.04	32.4%
30 Giugno 2025	$-0.04	$-0.04	2.0%
31 Marzo 2025	$-0.05	$-0.07	24.0%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 16

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue	$460M	$399M	$267M	$215M	$144M	$49M	$13M
Cost of Revenue	$191M	$147M	$96M	$74M	$52M	$17M	$4M
R&D Expense	$221M	$235M	$266M	$286M	$573M	$223M	$142M
SG&A Expense	$278M	$299M	$282M	$259M	$219M	$111M	$70M
Operating Income	$-229M	$-282M	$-367M	$-404M	$-700M	$-302M	$-203M
Interest Expense	·	$2M	$0	$0	$0	$181.0K	$293.0K
Interest Income	$33M	$37M	$40M	$15M	$2M	$5M	$8M
Other Non-op	$4M	$5M	$7M	$3M	$-10M	$7M	$938.0K
Pretax Income	$-178M	$-257M	$-335M	$-443M	$-704M	$-269M	$-194M
Income Tax	$-3M	$0	$0	$0	$0	$0	·
Net Income	$-176M	$-257M	$-335M	$-443M	$-704M	$-269M	$-195M
EPS (Basic)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·
EPS (Diluted)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·
Shares (Basic)	1,095,311,090	989,477,730	966,394,130	958,067,140	929,921,120	776,677,430	·
Shares (Diluted)	1,095,311,090	989,477,730	966,394,130	958,067,140	929,921,120	776,677,430	·
EBITDA	$-214M	$-270M	$-358M	·	$-694M	$-297M	·

Stato Patrimoniale 26

Metrica	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$680M	$450M	$790M	$1.01B	$964M	$442M	$76M
Short-term Investments	$10M	$330M	$16M	$0	$445M	$745M	$200M
Receivables	$106M	$85M	$59M	$40M	$47M	$5M	$4M
Inventory	$75M	$40M	$45M	$32M	$19M	$13M	$6M
Prepaid Expense	$37M	$42M	$23M	$36M	$18M	$11M	$7M
Current Assets	$1.02B	$1.05B	$940M	$1.12B	$1.50B	$1.22B	$292M
PP&E (Net)	$47M	$48M	$54M	$58M	$43M	$29M	$21M
PP&E (Gross)	$90M	$85M	$84M	$80M	$60M	$39M	$27M
Accum. Depreciation	$42M	$37M	$30M	$22M	$16M	$10M	$5M
Intangibles	$76M	$56M	$13M	$2M	$2M	$2M	$1M
Other Non-current Assets	$3M	$6M	·	·	·	·	·
Total Assets	$1.17B	$1.19B	$1.04B	$1.22B	$1.61B	$1.30B	$355M
Accounts Payable	$142M	$101M	$113M	$66M	$126M	$63M	$23M
Short-term Debt	$205M	$132M	$0	·	·	·	$6M
Current Liabilities	$416M	$299M	$203M	$140M	$193M	$98M	$47M
Capital Leases	$13M	$14M	$8M	$13M	$10M	$13M	$11M
Other Non-current Liabilities	$0	$325.0K	$325.0K	$0	·	·	·
Total Liabilities	$457M	$345M	$240M	$175M	$230M	$128M	$60M
Total Debt	$205M	$132M	·	·	·	·	·
Common Stock	$7.0K	$7.0K	$6.0K	$6.0K	$6.0K	$5.0K	$4.0K
Retained Earnings	$-2.63B	$-2.45B	$-2.20B	$-1.86B	$-1.42B	$-714M	$-445M
Treasury Stock	$29M	$21M	$21M	$12M	$4M	$0	·
AOCI	$30M	$51M	$38M	$26M	$-24M	$-15M	$5M
Stockholders' Equity	$716M	$841M	$796M	$1.05B	$1.38B	$1.17B	$295M
Liabilities + Equity	$1.17B	$1.19B	$1.04B	$1.22B	$1.61B	$1.30B	$355M
Shares Outstanding	1,106,389,340	1,082,614,740	977,151,270	962,455,850	955,363,980	878,110,260	682,372,470

Flusso di cassa 13

Metrica	2025	2024	2023	2022	2021	2020	2019
D&A	$15M	$12M	$9M	$8M	$6M	$5M	$4M
Stock-based Comp	$66M	$71M	$80M	$61M	$41M	$25M	$20M
Amort. of Intangibles	$6M	$3M	$700.0K	$500.0K	$500.0K	$300.0K	$305.0K
Other Non-cash	$-56M	$-40M	$48M	·	$108M	$23M	·
Operating Cash Flow	$-151M	$-215M	$-198M	$-368M	$-549M	$-216M	$-191M
CapEx	$8M	$6M	$7M	$25M	$18M	$10M	$6M
Investing Cash Flow	$308M	$-375M	$-11M	$420M	$250M	$-555M	$-15M
Stock Issued	$0	$217M	$0	$0	·	·	·
Net Stock Activity	$0	$217M	·	·	·	·	·
Financing Cash Flow	$72M	$350M	$-6M	$-2M	$820M	$1.13B	$219M
Net Change in Cash	$230M	$-240M	$-218M	$44M	$522M	$366M	$13M
Free Cash Flow	$-159M	$-221M	$-205M	·	$-568M	$-226M	·
Levered FCF	·	$-223M	·	·	·	·	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-49.9%	-70.7%	-137.4%	·	-485.1%	-616.5%	·
Net Margin	-38.1%	-64.4%	-125.5%	·	-488.2%	-549.3%	·
Pretax Margin	-38.8%	-64.4%	-125.5%	·	-487.4%	-549.3%	·
EBITDA Margin	-46.6%	-67.7%	-134.1%	·	-480.6%	-607.0%	·
ROA	-14.9%	-23.1%	-29.7%	·	-48.5%	-32.5%	·
ROE	-23.3%	-34.1%	-39.9%	·	-47.5%	-23.3%	·
ROIC	-24.5%	-29.0%	-46.1%	·	·	·	·

Liquidità e Solvibilità 4

Metrica	2025	2024	2023	2022	2021	2020	2019
Current Ratio	2.4	3.5	4.6	·	7.8	12.4	·
Quick Ratio	1.9	2.9	4.3	·	7.6	12.2	·
Debt / Equity	0.3	0.2	·	·	·	·	·
Interest Coverage	·	-125.2	·	·	·	-1667.4	·

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020	2019
Asset Turnover	0.4	0.4	0.2	·	0.1	0.1	·
Inventory Turnover	3.3	3.5	2.5	·	3.3	1.7	·
Receivables Turnover	4.8	5.5	5.4	·	5.5	10.9	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$0.65	$0.78	$0.82	·	$14.44	$13.32	·
Revenue / Share	$0.42	$0.40	$0.28	·	·	·	·
Cash Flow / Share	$-0.14	$-0.22	$-0.21	·	·	·	·
Cash / Share	$0.61	$0.42	$0.81	·	$10.09	$5.03	·
EPS (TTM)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	15.3%	49.6%	24.0%	49.0%	194.8%	·	·
Revenue CAGR 3Y	28.9%	40.4%	76.0%	·	·	·	·
Revenue CAGR 5Y	56.5%	·	·	·	·	·	·

Valutazione (TTM) 14

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$460M	$399M	$267M	$215M	$144M	$49M	·
Net Income TTM	$-176M	$-257M	$-335M	$-443M	$-704M	$-269M	·
Market Cap	$19.52B	$28.23B	$26.57B	·	$6.00B	$11.88B	·
Enterprise Value	$19.03B	$27.58B	·	·	·	·	·
P/E	-110.2	-100.7	-78.1	-66.7	-82.7	-386.7	·
P/S	42.4	70.7	99.6	·	41.6	242.7	·
P/B	27.3	33.6	33.4	·	4.4	10.2	·
P / Tangible Book	30.5	36.0	33.9	28.2	4.4	10.2	·
P / Cash Flow	-129.4	-131.4	-134.1	·	-10.9	-55.0	·
P / FCF	-122.8	-128.0	-129.4	·	-10.6	-52.5	·
EV / EBITDA	-88.8	-102.0	·	·	·	·	·
EV / FCF	-119.8	-125.1	·	·	·	·	·
EV / Revenue	41.4	69.1	·	·	·	·	·
Earnings Yield	-0.91%	-0.99%	-1.3%	-1.5%	-1.2%	-0.26%	·

Conto Economico 16

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$106M	$100M	$128M	$116M	$110M	$106M	$109M	$102M	$101M	$87M	$66M	$69M	$69M	$63M	$63M	$58M
Cost of Revenue	$48M	$38M	$62M	$47M	$43M	$38M	$42M	$37M	$35M	$34M	$25M	$25M	$24M	$21M	$21M	$20M
R&D Expense	$62M	$66M	$62M	$48M	$51M	$61M	$52M	$66M	$62M	$55M	$82M	$59M	$77M	$48M	$67M	$100M
SG&A Expense	$73M	$65M	$73M	$70M	$71M	$63M	$83M	$67M	$80M	$69M	$83M	$69M	$68M	$63M	$72M	$67M
Operating Income	$-76M	$-69M	$-69M	$-49M	$-55M	$-56M	$-68M	$-68M	$-76M	$-70M	$-124M	$-84M	$-90M	$-70M	$-97M	$-129M
Interest Expense	·	·	·	·	·	·	·	·	·	$113.0K	·	·	·	$0	·	·
Interest Income	$6M	$6M	$7M	$8M	$9M	$9M	$9M	$9M	$9M	$10M	$10M	$9M	$10M	$10M	$9M	$4M
Other Non-op	$5M	$162.0K	$495.0K	$-508.0K	$4M	$-197.0K	$1M	$3M	$-9M	$9M	$7M	$394.0K	$-1M	$1M	$10M	$4M
Pretax Income	$-52M	$-50M	$-53M	$-36M	$-41M	$-48M	$-82M	$-42M	$-80M	$-53M	$-95M	$-69M	$-121M	$-49M	$-62M	$-161M
Income Tax	$-1M	$1M	$-3M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$-51M	$-51M	$-50M	$-36M	$-41M	$-48M	$-82M	$-42M	$-80M	$-53M	$-95M	$-69M	$-121M	$-49M	$-62M	$-161M
EPS (Basic)	$-0.05	$-0.05	$-0.05	$-0.03	$-0.04	$-0.04	$-0.09	$-0.04	$-0.08	$-0.05	$-0.10	$-0.07	$-0.13	$-0.05	$-0.06	$-0.17
EPS (Diluted)	$-0.05	$-0.05	$-0.05	$-0.03	$-0.04	$-0.04	$-0.09	$-0.04	$-0.08	$-0.05	$-0.10	$-0.07	$-0.13	$-0.05	$-0.06	$-0.17
Shares (Basic)	1,116,973,380	1,107,390,590	·	1,102,072,680	1,091,933,150	1,080,825,300	·	981,687,390	975,937,790	973,145,760	·	968,767,730	964,817,310	961,444,780	·	959,085,960
Shares (Diluted)	1,116,973,380	1,107,390,590	·	1,102,072,680	1,091,933,150	1,080,825,300	·	981,687,390	975,937,790	973,145,760	·	968,767,730	964,817,310	961,444,780	·	959,085,960
EBITDA	$-76M	$-65M	·	$-49M	$-55M	$-53M	·	$-68M	$-76M	$-67M	·	$-84M	$-90M	$-67M	·	$-129M

Stato Patrimoniale 26

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$608M	$651M	$680M	$717M	$732M	$757M	$450M	$616M	$630M	$651M	·	$789M	$859M	$880M	·	$1.12B
Short-term Investments	$10M	$10M	$10M	$0	$0	$0	$330M	$0	$0	$0	·	$32M	$16M	$51M	·	$0
Receivables	$70M	$54M	$106M	$85M	$88M	$77M	$85M	$50M	$70M	$60M	·	$42M	$47M	$43M	·	$28M
Inventory	$91M	$86M	$75M	$67M	$62M	$53M	$40M	$40M	$42M	$38M	·	$44M	$36M	$38M	·	$29M
Prepaid Expense	$33M	$35M	$37M	$44M	$41M	$44M	$42M	$36M	$20M	$24M	·	$30M	$38M	$43M	·	$22M
Current Assets	$914M	$945M	$1.02B	$1.03B	$1.03B	$1.04B	$1.05B	$861M	$870M	$889M	·	$960M	$1.02B	$1.07B	·	$1.21B
PP&E (Net)	$46M	$47M	$47M	$49M	$50M	$50M	$48M	$51M	$51M	$52M	·	$55M	$56M	$58M	·	$51M
PP&E (Gross)	$94M	$92M	$90M	$89M	$89M	$89M	$85M	$87M	$85M	$85M	·	$83M	$82M	$83M	·	$71M
Accum. Depreciation	$47M	$45M	$42M	$41M	$39M	$39M	$37M	$36M	$34M	$32M	·	$28M	$26M	$24M	·	$20M
Intangibles	$86M	$76M	$76M	$55M	$57M	$56M	$56M	$52M	$44M	$12M	·	$2M	$2M	$1M	·	$2M
Other Non-current Assets	$4M	$3M	$3M	$2M	$3M	$3M	$6M	·	·	·	·	·	·	·	·	·
Total Assets	$1.07B	$1.10B	$1.17B	$1.16B	$1.16B	$1.17B	$1.19B	$985M	$987M	$988M	·	$1.04B	$1.11B	$1.17B	·	$1.30B
Accounts Payable	$137M	$126M	$142M	$100M	$107M	$103M	$101M	$121M	$127M	$88M	·	$55M	$67M	$66M	·	$90M
Short-term Debt	$238M	$214M	$205M	$203M	$175M	$173M	$132M	$113M	$70M	$48M	·	·	·	·	·	·
Current Liabilities	$429M	$393M	$416M	$360M	$332M	$320M	$299M	$286M	$252M	$192M	·	$125M	$133M	$125M	·	$156M
Capital Leases	$11M	$12M	$13M	$11M	$11M	$12M	$14M	$6M	$6M	$8M	·	$10M	$12M	$13M	·	$14M
Other Non-current Liabilities	$225.0K	$40.0K	$0	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	·	$325.0K	$325.0K	$325.0K	·	·
Total Liabilities	$468M	$434M	$457M	$399M	$372M	$363M	$345M	$318M	$283M	$226M	·	$163M	$174M	$169M	·	$193M
Total Debt	$238M	$214M	·	$203M	$175M	$173M	·	$113M	$70M	$48M	·	·	·	·	·	·
Common Stock	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$6.0K	$6.0K	$6.0K	·	$6.0K	$6.0K	$6.0K	·	$6.0K
Retained Earnings	$-2.73B	$-2.68B	$-2.63B	$-2.58B	$-2.54B	$-2.50B	$-2.45B	$-2.37B	$-2.33B	$-2.25B	·	$-2.10B	$-2.03B	$-1.91B	·	$-1.80B
Treasury Stock	$34M	$31M	$29M	$29M	$21M	$21M	$21M	$21M	$21M	$21M	·	$21M	$21M	$17M	·	$11M
AOCI	$214.0K	$15M	$30M	$40M	$46M	$49M	$51M	$28M	$43M	$39M	·	$48M	$52M	$17M	·	$40M
Stockholders' Equity	$607M	$662M	$716M	$760M	$792M	$811M	$841M	$668M	$704M	$762M	$796M	$881M	$932M	$1.00B	$1.05B	$1.11B
Liabilities + Equity	$1.07B	$1.10B	$1.17B	$1.16B	$1.16B	$1.17B	$1.19B	$985M	$987M	$988M	·	$1.04B	$1.11B	$1.17B	·	$1.30B
Shares Outstanding	1,122,445,390	1,110,232,620	1,106,389,340	1,105,865,950	1,099,112,890	1,084,164,200	1,077,702,540	984,356,170	981,398,140	973,285,510	977,151,270	969,037,150	968,566,280	963,688,740	962,455,850	959,724,940

Flusso di cassa 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$4M	$4M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$3M	$2M	$2M
Stock-based Comp	$12M	$14M	$16M	$17M	$17M	$16M	$17M	$17M	$19M	$18M	$20M	$22M	$21M	$17M	$16M	$19M
Amort. of Intangibles	$2M	$2M	$1M	$2M	$2M	$2M	$1M	$700.0K	$800.0K	$700.0K	$200.0K	$200.0K	·	·	·	·
Other Non-cash	·	$22M	·	·	·	$-33M	·	·	·	$-58M	·	·	·	$-39M	·	·
Operating Cash Flow	$-63M	$-12M	$-26M	$-32M	$-31M	$-62M	$-56M	$-27M	$-42M	$-90M	$-15M	$-55M	$-59M	$-69M	$-109M	$-126M
CapEx	$1M	$1M	$677.0K	$3M	$3M	$2M	$3M	$1M	$741.0K	$974.0K	$222.0K	$2M	$2M	$4M	$4M	$7M
Investing Cash Flow	$-1M	$-22M	$-11M	$-4M	$-3M	$326M	$-348M	$-30M	$-846.0K	$3M	$14M	$-14M	$43M	$-54M	$-4M	$568M
Financing Cash Flow	$19M	$6M	$-430.0K	$21M	$9M	$43M	$238M	$42M	$22M	$48M	$393.0K	$-1M	$-1M	$-4M	$-199.0K	$709.0K
Net Change in Cash	$-44M	$-28M	$-38M	$-15M	$-25M	$308M	$-166M	$-14M	$-21M	$-39M	$666.0K	$-70M	$-20M	$-128M	$-111M	$439M
Free Cash Flow	·	$-13M	·	·	·	$-63M	·	·	·	$-91M	·	·	·	$-73M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-91M	·	·	·	·	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-72.0%	-69.7%	·	-42.0%	-49.9%	-52.9%	·	-66.3%	-75.7%	-80.7%	·	-120.7%	-130.0%	-110.7%	·	-223.5%
Net Margin	-47.8%	-51.2%	·	-31.0%	-37.0%	-45.5%	·	-40.8%	-79.9%	-61.4%	·	-99.9%	-175.6%	-78.3%	·	-280.1%
Pretax Margin	-48.8%	-49.8%	·	-31.0%	-37.0%	-45.5%	·	-40.8%	-79.9%	-61.4%	·	-99.9%	-175.6%	-78.3%	·	-280.1%
EBITDA Margin	-72.0%	-65.7%	·	-42.0%	-49.9%	-49.6%	·	-66.3%	-75.7%	-77.2%	·	-120.7%	-130.0%	-106.5%	·	-223.5%
ROA	-4.5%	-4.5%	·	-3.4%	-3.8%	-4.5%	·	-4.1%	-7.7%	-5.0%	·	-5.9%	-9.6%	-3.7%	·	-10.7%
ROE	-7.3%	-6.9%	·	-5.0%	-5.5%	-6.2%	·	-5.4%	-9.8%	-6.1%	·	-7.0%	-11.3%	-4.3%	·	-12.0%
ROIC	-8.9%	-8.2%	·	-5.1%	-5.7%	-5.7%	·	-8.7%	-9.8%	-8.7%	·	-9.5%	-9.6%	-6.9%	·	-11.6%

Liquidità e Solvibilità 4

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	2.1	2.4	·	2.9	3.1	3.3	·	3.0	3.5	4.6	·	7.7	7.6	8.6	·	7.8
Quick Ratio	1.6	1.8	·	2.2	2.5	2.6	·	2.3	2.8	3.7	·	6.9	6.9	7.8	·	7.4
Debt / Equity	0.4	0.3	·	0.3	0.2	0.2	·	0.2	0.1	0.1	·	·	·	·	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-622.2	·	·	·	·	·	·

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.0	·	0.0
Inventory Turnover	0.6	0.6	·	0.9	0.8	0.8	·	0.9	0.9	0.9	·	0.7	0.8	0.7	·	1.0
Receivables Turnover	1.3	1.5	·	1.7	1.4	1.6	·	2.2	1.7	1.7	·	2.0	1.9	1.6	·	2.4

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.54	$0.60	·	$0.69	$0.72	$0.75	·	$0.68	$0.72	$0.78	·	$0.91	$0.96	$1.04	·	$1.15
Revenue / Share	$0.10	$0.09	·	$0.11	$0.10	$0.10	·	$0.10	$0.10	$0.09	·	$0.07	$0.07	$0.07	·	$0.06
Cash Flow / Share	·	$-0.01	·	·	·	$-0.06	·	·	·	$-0.09	·	·	·	$-0.07	·	·
Cash / Share	$0.54	$0.59	·	$0.65	$0.67	$0.70	·	$0.63	$0.64	$0.67	·	$0.81	$0.89	$0.91	·	$1.17
EPS (TTM)	$-0.18	$-0.17	·	$-0.20	$-0.21	$-0.25	·	$-0.27	$-0.30	$-0.35	·	$-0.31	$-0.41	$-0.42	·	$-0.63

Valutazione (TTM) 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$450M	$453M	·	$442M	$428M	$418M	·	$356M	$323M	$291M	·	$263M	$252M	$231M	·	$197M
Net Income TTM	$-188M	$-178M	·	$-207M	$-213M	$-252M	·	$-271M	$-298M	$-339M	·	$-301M	$-393M	$-410M	·	$-593M
Market Cap	$21.33B	$20.88B	·	$37.48B	$38.44B	$39.18B	·	$23.76B	$17.01B	$15.59B	·	$23.56B	$26.86B	$32.05B	·	$32.82B
Enterprise Value	$20.95B	$20.44B	·	$36.96B	$37.88B	$38.60B	·	$23.26B	$16.45B	$14.99B	·	·	·	·	·	·
P/E	-105.6	-110.6	·	-169.4	-166.5	-144.6	·	-89.4	-57.8	-45.8	·	-78.4	-67.6	-79.2	·	-54.3
P/S	47.4	46.1	·	84.9	89.8	93.7	·	66.8	52.7	53.6	·	89.4	106.7	138.7	·	166.9
P/B	35.1	31.5	·	49.3	48.5	48.3	·	35.6	24.2	20.5	·	26.7	28.8	32.0	·	29.7
P / Tangible Book	40.9	35.6	·	53.2	52.3	51.9	·	38.6	25.8	20.8	·	26.8	28.9	32.1	·	29.7
P / Cash Flow	·	-1753.1	·	·	·	-635.0	·	·	·	-173.0	·	·	·	-462.6	·	·
EV / Revenue	46.6	45.1	·	83.7	88.5	92.3	·	65.4	51.0	51.5	·	·	·	·	·	·
Earnings Yield	-0.95%	-0.90%	·	-0.59%	-0.60%	-0.69%	·	-1.1%	-1.7%	-2.2%	·	-1.3%	-1.5%	-1.3%	·	-1.8%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$460M	$399M	$267M	$215M	$144M
Margine Operativo %	-49.9%	-70.7%	-137.4%	·	-485.1%
Utile netto	$-176M	$-257M	$-335M	$-443M	$-704M
EPS Diluito	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.3	0.2	·	·	·
Rapporto corrente	2.4	3.5	4.6	·	7.8
Quick Ratio	1.9	2.9	4.3	·	7.6

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-159M	$-221M	$-205M	·	$-568M

Proprietari istituzionali (13F) 97 filer · $813.8M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 97

Valore detenuto $813.8M

Nuove posizioni 16

Posizioni chiuse 21

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
16 (-4 vs trimestre precedente)	21 (-20 vs trimestre precedente)	29 (+5 vs trimestre precedente)	26 (-17 vs trimestre precedente)	+15.2M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
RTW INVESTMENTS, LP	$124.906.608	6.574.032	15,35%	Azioni
TCG Crossover Management, LLC	$116.614.913	6.137.627	14,33%	Azioni
RA CAPITAL MANAGEMENT, L.P.	$109.127.127	5.743.533	13,41%	Azioni
ADAR1 Capital Management, LLC	$64.011.646	3.369.034	7,87%	Azioni
FMR LLC	$53.489.066	2.815.214	6,57%	Azioni
GOLDMAN SACHS GROUP INC	$43.994.120	2.315.480	5,41%	Azioni
Woodline Partners LP	$41.938.567	2.207.293	5,15%	Azioni
Frazier Life Sciences Management, L.P.	$36.144.080	1.902.320	4,44%	Azioni
BAMCO INC /NY/	$30.850.186	1.623.694	3,79%	Azioni
TWO SIGMA INVESTMENTS, LP	$24.688.486	1.299.394	3,03%	Azioni
CITADEL ADVISORS LLC	$24.409.414	1.284.706	3,00%	Azioni
Rock Springs Capital Management LP	$15.479.433	814.707	1,90%	Azioni
BlackRock, Inc.	$12.624.778	664.462	1,55%	Azioni
JANE STREET GROUP, LLC	$9.054.279	476.541	1,11%	Azioni
B Group, Inc.	$8.562.274	450.646	1,05%	Azioni
SCHRODER INVESTMENT MANAGEMENT GROUP	$7.238.204	393.167	0,89%	Azioni
NAN FUNG TRINITY (HK) LTD	$6.582.854	346.466	0,81%	Azioni
Aberdeen Group plc	$5.914.586	311.294	0,73%	Azioni
CITIGROUP INC	$5.714.725	300.775	0,70%	Azioni
Spruce Street Capital LP	$5.303.090	279.110	0,65%	Azioni
AMERIPRISE FINANCIAL INC	$4.810.249	253.171	0,59%	Azioni
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$4.692.658	246.982	0,58%	Azioni
Hudson Bay Capital Management LP	$4.085.000	215.000	0,50%	Azioni
JANE STREET GROUP, LLC	$3.864.600	203.400	0,47%	Opzione Put
Nantahala Capital Management, LLC	$3.800.000	200.000	0,47%	Azioni
NEXTBio Capital Management LP	$3.483.878	183.362	0,43%	Azioni
SUPERSTRING CAPITAL MANAGEMENT LP	$2.960.447	155.813	0,36%	Azioni
Seven Fleet Capital Management LP	$2.924.756	136.016	0,36%	Azioni
MARSHALL WACE, LLP	$2.797.123	147.217	0,34%	Azioni
D. E. Shaw & Co., Inc.	$2.682.002	141.158	0,33%	Azioni
Privium Fund Management B.V.	$2.321.591	122.189	0,29%	Azioni
STATE STREET CORP	$2.296.074	120.846	0,28%	Azioni
AXA Investment Managers S.A.	$2.230.436	65.814	0,27%	Azioni
ALPS ADVISORS INC	$2.098.189	110.431	0,26%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$2.086.200	109.800	0,26%	Opzione Put
DIMENSIONAL FUND ADVISORS LP	$1.934.621	101.997	0,24%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.454.735	76.565	0,18%	Azioni
Legal & General Group Plc	$1.358.116	71.461	0,17%	Azioni
UBS Group AG	$1.319.626	69.454	0,16%	Azioni
Orion Portfolio Solutions, LLC	$1.310.400	36.259	0,16%	Azioni
Virtus Investment Advisers, LLC	$1.294.356	68.124	0,16%	Azioni
Headlands Technologies LLC	$1.292.190	68.010	0,16%	Azioni
MORGAN STANLEY	$1.242.619	65.401	0,15%	Azioni
DCF Advisers, LLC	$1.206.500	63.500	0,15%	Azioni
CITADEL ADVISORS LLC	$953.800	50.200	0,12%	Opzione Put
Quadrature Capital Ltd	$741.532	39.028	0,09%	Azioni
WOLVERINE TRADING, LLC	$714.581	21.700	0,09%	Opzione Put
WealthPlan Investment Management, LLC	$698.459	36.761	0,09%	Azioni
NORTHERN TRUST CORP	$455.601	23.979	0,06%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$453.701	23.879	0,06%	Azioni

Mostra tutti i 97 proprietari istituzionali →

Insider aziendali 20 insider · 11 dirigenti · 10 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
Ying Du	Chairperson & CEO	02 Luglio 2026 A	1.221.401	0	15	$-8.578.643
Yajing Chen	Chief Financial Officer	19 Agosto 2026 S	35.635	0	8	$-239.260
William Ki Chul Cho	Chief Financial Officer	03 Aprile 2023 M	53.747	0	0	$0
Joshua L Smiley	President and Chief Operating Officer	06 Aprile 2026 S	117.602	0	3	$-294.354
Rafael Amado	President, Head of Global Oncology Research and Development	06 Aprile 2026 S	57.022	0	5	$-674.984
Harald Reinhart	President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases	25 Giugno 2024 M	62.619	0	0	$0
Yi Liang	CCO & President, Greater China	25 Giugno 2022 A	104.847	0	0	$0
Tao Fu	President & COO	28 Ottobre 2021 S	77.500	0	0	$0
Frazor Titus Edmondson III	Chief Legal Officer	25 Giugno 2026 M	30.346	0	8	$-1.005.489
Yizhe Wang	Operating Partner	11 Maggio 2026 A	·	0	0	$0
Alan B. Sandler	Head of Global Dev., Oncology	25 Giugno 2022 A	28.985	0	0	$0
Richard Gaynor	Direttore	01 Luglio 2026 P	80.737	2	0	$65.804
Nisa Leung	Direttore	17 Giugno 2026 A	96.297	0	0	$0
Michel Vounatsos	Direttore	17 Giugno 2026 A	72.787	0	0	$0
Scott W Morrison	Direttore	17 Giugno 2026 A	56.904	0	0	$0
John D. Diekman	Direttore	17 Giugno 2026 A	122.140	0	0	$0
MOULDER LEON O JR	Direttore	17 Giugno 2026 A	94.973	0	0	$0
WIRTH PETER	Direttore	17 Giugno 2026 A	416.121	0	0	$0
Kai-Xian Chen	Direttore	31 Dicembre 2024 D	39.525	0	0	$0
William Lis	·	12 Agosto 2026 S	41.931	0	2	$-340.004

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 8 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
BBP · ETFis Series Trust I	1,47%	79.505 NS	31 Luglio 2026	N-PORT
PGJ · Invesco Exchange-Traded Fund Trust	0,87%	28.106 SH	01 Ottobre 2026	Giornaliero
IBB · iShares Trust	0,16%	684.677 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,08%	3.144 SH	01 Ottobre 2026	Giornaliero
DFEM · Dimensional ETF Trust	0,01%	26.020 NS	31 Luglio 2026	N-PORT
DFSE · Dimensional ETF Trust	0,01%	1.660 NS	31 Luglio 2026	N-PORT
DFAE · Dimensional ETF Trust	0,00%	10.010 NS	31 Luglio 2026	N-PORT
DFAX · Dimensional ETF Trust	0,00%	2.911 NS	31 Luglio 2026	N-PORT

ZLAB Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 15 analisti COMPRA

Target mediano $31.84 +30,9%

2 13,3% Acquisto forte

10 66,7% Compra

3 20,0% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

12 analisti · 2026-09-29

Target medio $33.14 +36,2%

Ora Prezzo attuale $24.33

Basso$24.25 Media$33.14 Alto$50.00

Ultime notizie Notizie recenti che menzionano questa società

23

Zai Lab (ZLAB), Amgen (AMGN) collaborano per valutare la terapia combinata per il cancro ai polmoni Yahoo Finance · 5 mesi, 2 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

ZLAB Zai Lab Limited - American Depositary Shares

ZLAB Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

ZLAB Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Informazioni su Zai Lab Limited - American Depositary Shares Panoramica della società da Wikipedia

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Proprietari istituzionali (13F) 97 filer · $813.8M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 20 insider · 11 dirigenti · 10 direttori

Proprietà ETF Posseduti da 8 ETF

ZLAB Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi